A ruling by U.S. District Judge Matthew Kacsmaryk in Texas, a Trump appointee, put a halt on government approval of the drug, potentially decimating access to medication abortion nationwide. But just minutes later, a federal judge in Washington, Obama appointee U.S. District Judge Thomas O. Rice, ordered the Food and Drug Administration not to make any changes that would restrict access to the drug in 17 states and D.C. that sued to expand access to mifepristone.
Kacsmaryk's ruling in Texas means health care providers could be barred from prescribing mifepristone, even in states where abortion is legal. In-clinic, procedural abortion care will not be affected by the ruling. The decision"will unleash a public health crisis by removing health care options for millions of people," said Jenny Ma, senior counsel at the Center for Reproductive Rights.
"Simply put: this decision undermines the FDA’s ability to approve safe and effective medications—from chemotherapy drugs, to asthma medicine, to blood pressure pills, to insulin—based on science, not politics," Harris said in a statement.Even before the U.S. Supreme Court last year struck down the constitutional right to abortion granted by Roe v.
U.S. Attorney General Merrick Garland said that the Justice Department"strongly disagrees" with the ruling from Texas and will appeal it, and is reviewing the decision from Washington. While the FDA could choose to restart the approval process if an effort to revoke approval succeeds, this may take years, Chaiten said.
Trump 34 felony charges Biden Putin Xi Zelenskyy China Taiwan Tsai PFAS Pollution by U.S. forces. Japan ,Okinawa ,Yokota
Law Law Latest News, Law Law Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: nbcbayarea - 🏆 596. / 51 Read more »
Source: YahooNews - 🏆 380. / 59 Read more »
Source: MSNBC - 🏆 469. / 51 Read more »